Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
How does frankincense work to reduce inflammation in the body?
Frankincense contains boswellic acids, particularly acetyl-11-keto-beta-boswellic acid (AKBA), which inhibit the 5-lipoxygenase enzyme responsible for producing inflammatory leukotrienes. Unlike NSAIDs that target cyclooxygenase pathways, frankincense blocks leukotriene synthesis, reducing inflammation through a different mechanism. This action may explain its effectiveness for inflammatory conditions while causing fewer gastrointestinal side effects than conventional anti-inflammatory drugs. (Evidence Level B)
Can I take frankincense with blood thinners or anticoagulant medications?
Frankincense should be used cautiously with blood thinners and anticoagulant medications. The herb possesses mild antiplatelet properties that may enhance bleeding risk when combined with warfarin, aspirin, clopidogrel, or similar medications. Additionally, combining frankincense with NSAIDs could potentially increase stomach irritation. Patients taking anticoagulants should consult their healthcare provider before starting frankincense supplements, as monitoring and dosage adjustments may be necessary. (Evidence Level C)
What is the recommended dosage for frankincense supplements?
The standard adult dosage for frankincense (Boswellia) is 300-500mg of boswellic acid extract taken three times daily with meals, providing a total daily intake of 900-1500mg. Products should be standardized to contain 60-65% boswellic acids for therapeutic effectiveness. For arthritis and inflammatory conditions, consistent use for 4-12 weeks may be required before full benefits are observed. Always follow specific product label instructions. (Evidence Level B)
Is frankincense safe to use during pregnancy and breastfeeding?
Frankincense is considered unsafe during pregnancy and should be avoided. Traditional evidence suggests it may stimulate uterine contractions, potentially causing miscarriage or premature labor. There is insufficient safety data for breastfeeding women, so avoidance is recommended. The essential oil form should also be avoided during pregnancy. Women who are pregnant, planning pregnancy, or breastfeeding should consult a qualified healthcare provider before using any frankincense products. (Evidence Level D/Traditional)
What are the health benefits of frankincense for arthritis and joint pain?
Frankincense has demonstrated effectiveness for arthritis in clinical studies. The boswellic acids reduce joint inflammation, decrease pain, and may improve physical function in both osteoarthritis and rheumatoid arthritis. Research indicates improvements in pain scores, stiffness, and mobility after 4-8 weeks of consistent use. While evidence is promising, frankincense works best as a complementary therapy alongside conventional arthritis treatments rather than a complete replacement. (Evidence Level B)
Fiche d'information compilée à partir de PubMed
Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.
Compilé à partir de 29 articles PubMed · modèle : gemma4:31b
Résumé
Frankincense, derived from Boswellia species such as B. sacra, is a resinous extract used traditionally for its anti-inflammatory, antimicrobial, and analgesic properties [PMID:27117114, PMID:35807419].
Contexte
Frankincense is an oleo-gum-resin obtained by wounding trees of the genus Boswellia, including B. sacra (endemic to Oman) and B. serrata (native to India, Middle East, and Northern Africa) [PMID:33151656, PMID:35789857, PMID:30566477].
Usages traditionnels
It has been used for centuries in Ayurvedic, Chinese, and Arab traditional medicines to treat inflammatory conditions, asthma, arthritis, gastric and hepatic disorders, and male fertility [PMID:33151656, PMID:35222678, PMID:35897864, PMID:24716181]. It is also used as incense in religious and cultural ceremonies [PMID:33151656, PMID:35243948].
Composés actifs
The primary bioactive components are triterpenes, specifically boswellic acids (such as 11-keto-β-acetyl-boswellic acid and AKBA), and diterpenes, including cembranoids [PMID:27117114, PMID:34412004, PMID:24716181]. Essential oils contain mono- and diterpenes, with identified odorants including α-pinene, β-myrcene, and linalool [PMID:27117114, PMID:25468535].
Mécanisme d'action
Boswellia extracts exhibit anti-inflammatory, antioxidant, and anti-neoplastic activities [PMID:33235693, PMID:23237355]. In animal models, B. sacra methanolic extract suppressed oxidative stress and apoptosis in the testis while increasing antioxidant enzyme activity (superoxide dismutase and catalase) [PMID:35897864].
Preuves cliniques
Preuve AKnee Osteoarthritis
Phytoextracts from the Boswellia genus were evaluated for efficacy using WOMAC and VAS scores [PMID:39314013]
A systematic review of RCTs was conducted to assess the effectiveness of B. serrata extracts [PMID:19091760]
Preuve DPancreatic Cancer
Essential oil from B. sacra induced human pancreatic cancer cell death in vitro and in a xenograft murine model [PMID:23237355]
Preuve DPain (Analgesia)
Crude extracts and essential oils of B. sacra showed analgesic effects in mice, comparable to aspirin in acetic acid-induced writhing tests [PMID:25312172]
Preuve DType II Diabetes (Rat model)
B. sacra oleo-gum resin extracts demonstrated antidiabetic and antioxidant properties in STZ-induced diabetic rats [PMID:39167989]
Sécurité et effets indésirables
B. serrata extracts have not been linked to acute liver injury or serum aminotransferase elevations [PMID:33151656]. Allergic reactions to frankincense have been described but are reported as very rare [PMID:27975355]. One case of Boswellia resin-associated mania was reported [PMID:35426834].
Synthèse des preuves
Evidence ranges from high-level systematic reviews and meta-analyses for osteoarthritis and general inflammation to preliminary in vitro and animal studies for cancer, diabetes, and male fertility.
2.PMID: 33151656 (2012) — Boswellia serrata, a potential antiinflammatory agent: an overview. · Indian journal of pharmaceutical sciences
3.PMID: 35426834 (2022) — Boswellia Resin (Frankincense)-Associated Mania. · American journal of therapeutics
4.PMID: 37761150 (2023) — Antimicrobial Activity of Frankincense (Boswellia sacra) Oil and Smoke against Pathogenic and Airborne Microbes. · Foods (Basel, Switzerland)
5.PMID: 35789857 (2022) — Genome structure and evolutionary history of frankincense producing Boswellia sacra. · iScience
Sources gouvernementales
Aucune monographie gouvernementale directe n'est disponible pour cette plante. Le contenu ci-dessous est généré par IA et n'a pas été vérifié par rapport à une source gouvernementale faisant autorité. Utilisez les liens de recherche pour consulter les sources officielles avant de vous fier à ces informations.
PMID: 39942962 (2025) — Aromatherapy and Essential Oils: Holistic Strategies in Complementary and Alternative Medicine for Integral Wellbeing. · Plants (Basel, Switzerland)
7.PMID: 23237355 (2012) — Frankincense essential oil prepared from hydrodistillation of Boswellia sacra gum resins induces human pancreatic cancer cell death in cultures and in a xenograft murine model. · BMC complementary and alternative medicine
9.PMID: 35243948 (2022) — Frankincense diterpenes as a bio-source for drug discovery. · Expert opinion on drug discovery
10.PMID: 30566477 (2018) — Endogenous phytohormones of frankincense producing Boswellia sacra tree populations. · PloS one
11.PMID: 34412004 (2021) — Cembranoids from Boswellia species. · Phytochemistry
12.PMID: 41124237 (2025) — Compositional Analysis of Cultivated and Wild-Harvested Boswellia sacra Frankincense Resin Essential Oils in Oman. · Chemistry & biodiversity
13.PMID: 33235693 (2020) — Effect of Boswellia species on the metabolic syndrome: A review. · Iranian journal of basic medical sciences
14.PMID: 27975355 (2016) — [Christmas from an allergist's perspective]. · Deutsche medizinische Wochenschrift (1946)
15.PMID: 32325952 (2020) — In Vitro Antimicrobial Activity of Frankincense Oils from Boswellia sacra Grown in Different Locations of the Dhofar Region (Oman). · Antibiotics (Basel, Switzerland)
16.PMID: 25468535 (2015) — Identification of odorants in frankincense (Boswellia sacra Flueck.) by aroma extract dilution analysis and two-dimensional gas chromatography-mass spectrometry/olfactometry. · Phytochemistry
17.PMID: 33028915 (2020) — Roles of ethylene, jasmonic acid, and salicylic acid and their interactions in frankincense resin production in Boswellia sacra Flueck. trees. · Scientific reports
18.PMID: 38816637 (2024) — Chemical Constituents and Pharmacological Properties of Frankincense: Implications for Anticancer Therapy. · Chinese journal of integrative medicine
19.PMID: 35807419 (2022) — Effects of Frankincense Compounds on Infection, Inflammation, and Oral Health. · Molecules (Basel, Switzerland)
20.PMID: 39314013 (2024) — Efficacy of Extracts of Oleogum Resin of Boswellia in the Treatment of Knee Osteoarthritis: A Systematic Review and Meta-Analysis. · Phytotherapy research : PTR
21.PMID: 39167989 (2024) — Antidiabetic and antioxidant properties of Boswellia sacra oleo-gum in streptozotocin-induced diabetic rats. · Journal of Ayurveda and integrative medicine
22.PMID: 29492734 (2018) — Conformational analysis of macrocyclic frankincense (Boswellia) diterpenoids. · Journal of molecular modeling
23.PMID: 35222678 (2022) — Taxonomical Investigation, Chemical Composition, Traditional Use in Medicine, and Pharmacological Activities of Boswellia sacra Flueck. · Evidence-based complementary and alternative medicine : eCAM
24.PMID: 35897864 (2022) — Beneficial Effect of Methanolic Extract of Frankincense (Boswellia Sacra) on Testis Mediated through Suppression of Oxidative Stress and Apoptosis. · Molecules (Basel, Switzerland)
26.PMID: 24716181 (2013) — Frankincense ( rǔ xiāng; boswellia species): from the selection of traditional applications to the novel phytotherapy for the prevention and treatment of serious diseases. · Journal of traditional and complementary medicine
27.PMID: 39401649 (2025) — Triterpenoids from Frankincense and Boswellia: A focus on their pharmacology and 13C-NMR assignments. · Phytochemistry
28.PMID: 25312172 (2014) — Analgesic effects of crude extracts and fractions of Omani frankincense obtained from traditional medicinal plant Boswellia sacra on animal models. · Asian Pacific journal of tropical medicine